Barrett's esophagus: chemoprevention - 29/08/11
Doi : 10.1016/S1052-5157(03)00039-4
Rhonda F Souza, MD ⁎, a, b 
, Stuart J Spechler, MD a
, Stuart J Spechler, MD a a Division of Gastroenterology, Dallas VA Medical Center and University of Texas-Southwestern Medical School, University of Texas-Southwestern Medical Center at Dallas, MC #111B1, 4500 South Lancaster Road, Dallas, TX 75216, USA
b Harold C. Simmons Comprehensive Cancer Center, 5323 Harry Hines Blvd., University of Texas-Southwestern Medical Center at Dallas, Dallas, TX 75390, USA
*Corresponding author. Division of Gastroenterology, Dallas VA Medical Center and University of Texas-Southwestern Medical School, University of Texas-Southwestern Medical Center at Dallas, MC #111B1, 4500 South Lancaster Road, Dallas, TX 75216.
Plan
 | Supported by the Office of Medical Research, Department of Veteran's Affairs, Dallas, TX, the Glaxo Wellcome Institute for Digestive Health, and the National Institutes of Health DK63621 (R.F. Souza). |
© 2003
Publié par Elsevier Masson SAS.
Vol 13 - N° 3
P. 419-432 - juillet 2003 Retour au numéro
Article précédent
- Medical management of Barrett's esophagus
- Thomas J Lee, Peter J Kahrilas
- Surgical therapies in Barrett's esophagus
- Lars Lundell
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?